Skip to main content
. 2014 Mar 27;9(3):e89449. doi: 10.1371/journal.pone.0089449

Figure 6. Definition of a standardized method to define the best therapeutic strategy.

Figure 6

To validate this method two phases are required. An ANALYTICAL PHASE: This phase concerns approximately twenty patients and is dedicated to the definition of an ideal decisional score considering the clinical/pathological and genetic parameters and in vitro/in vivo experiments. Based on this prospective study on a small number of patients, we observed a strict correlation between the cell and the patient response to a given drug with a success rate of 100% for our methodology, which aims at the determination of the most efficient treatment. If a strong correlation exists between our score and the success to the treatment a PROSPECTIVE PHASE will be envisaged. For this trial, treatments will be administered according to the best decisional score.